PHEBRA POTASSIUM PHOSPHATE CONCENTRATED Injection

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

monobasic potassium phosphate, Quantity: 109.33 mg/mL; dibasic potassium phosphate, Quantity: 105.33 mg/mL

Verfügbar ab:

Phebra Pty Ltd

Darreichungsform:

Injection, intravenous infusion

Zusammensetzung:

Excipient Ingredients: water for injections

Verabreichungsweg:

Intravenous

Einheiten im Paket:

10mL x 10

Verschreibungstyp:

Not scheduled. Not considered by committee

Anwendungsgebiete:

INDICATIONS AS AT 01 JANUARY 1991 : Treatment of severe hypophosphataemia (serum levels <0.3mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. Lowering the pH of urine. The treatment of potassium depletion in patients with hypokalemia. IV administration is indicated when the patient is unable to take potassium orally or if hypokalemia is severe.

Produktbesonderheiten:

Visual Identification: Clear colourless solution; Container Type: Vial; Container Material: Glass; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Registered

Berechtigungsdatum:

1991-10-14